Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: The Minnesota Heart Survey

European Journal of Preventive Cardiology

Volumn 16, Issue 1, 2009, Pages 16-20

  Lee, Duk Hee ^a,b   Buijsse, Brian ^d,e   Steffen, Lyn ^b   Holtzman, Jordan ^c   Luepker, Russell ^b   Jacobs, David R ^b  

^a Kyungpook National University School of Medicine   (South Korea)

^b School of Public Health   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

aging; cardiovascular diseases; risk assessment; serum gamma glutamyltransferase

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX RATIO; SYSTOLIC BLOOD PRESSURE; BLOOD; DRINKING BEHAVIOR; HEALTH SURVEY; MIDDLE AGED; MOTOR ACTIVITY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HEALTH BEHAVIOR; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MINNESOTA; MOTOR ACTIVITY; RISK ASSESSMENT; SEX FACTORS; SMOKING;

EID: 65649115449     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32830aba5c     Document Type: Article

References (27)

1. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P, Sundvall J, et al Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women. Eur Heart J 2006; 27: 2170–2176.
2. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H; Vorarlberg Health Monitoring and Promotion Program Study Group. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163 944 Austrian adults Circulation 2005; 112: 2130–2137.
3. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007; 27: 127–133.
4. Meisinger C, Doring A, Schneider A, Lowel H; KORA Study Group Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 2006; 189: 297–302.
5. Bots ML, Salonen JT, Elwood PC, Nikitin Y, Freire de Concalves A, Inzitari D, et al Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project J Epidemiol Community Health 2002; 56 (Suppl 1):i25–i29.
6. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31: 1851–1855.
7. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake. Analysis of the British Women's Heart and Health Study and meta-analysis. Arterioscler Thromb Vasc Biol 2007; 27: 2729–2735.
8. Whitfield JB. Serum gamma-glutamyltransferase and risk of disease. Clin Chem 2007; 53: 1–2.
9. Luepker RV, Jacobs DR, Gillum RF, Folsom AR, Prineas RJ, Blackburn H. Population risk of cardiovascular disease: the Minnesota Heart Survey. J Chronic Dis 1985; 38: 671–682.
10. Arnett DK, Jacobs DR Jr, Luepker RV, Blackburn H, Armstrong C, Claas SA. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980–1982 to 2000–2002. Circulation 2005; 112: 3884–3891.
11. Arnett DK, McGovern PG, Jacobs DR Jr, Shahar E, Duval S, Blackburn H, et al Fifteen-year trends in cardiovascular risk factors (1980–1982 through 1995–1997): the Minnesota Heart Survey. Am J Epidemiol 2002; 156: 929–335.
12. National Heart Lung and Blood Institute. Lipid and lipoprotein analysis. Manual of operations, Lipid Research Clinics Program. Vol 1. Bethesda, MD: National Heart, Lung, and Blood Institute. HEW Publication (NIH); 1974. pp. 75–628.
13. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982; 28: 1379–1388.
14. Luepker RV, Arnett DK, Jacobs DR Jr, Duval S, Folsom AR, Armstrong C, et al Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am J Med 2006; 119: 42–49.
15. Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O, Marsik C. Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem 2007; 53: 940–946.
16. Lee D-H, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49: 1358–1366.
17. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM etal; Mexico City diabetes study. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study Diabetes Care 2005; 28: 1757–1762.
18. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 2007; 53: 71–77.
19. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38: 535–539.
20. Grundy SM. Gamma-glutamyl transferase: another biomarker for metabolic syndrome and cardiovascular risk Arterioscler Thromb Vasc Biol 2007; 27: 4–7.
21. Lee DH, Steffes MW, Jacobs DR Jr. Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia 2008; 51: 402–407.
22. Ha MH, Lee DH, Jacobs DR. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999–2002. Environ Health Perspect 2007; 115: 1204–1209.
23. Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR Jr. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999–2002. Diabetologia 2007; 50: 1841–1851.
24. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, et al A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999–2002. Diabetes Care 2006; 29: 1638–1644.
25. Lim JS, Lee DH, Park JY, Jin SH, Jacobs DR Jr. A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 2007; 53: 1092–1098.
26. Martin I, Grotewiel MS. Oxidative damage and age-related functional declines. Mech Ageing Dev 2006; 127: 411–423.
27. Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004; 2: 274–302.